BIOMAT Database Logo BIOMAT Database Logo

In vitro activity of azthreonam and Ro 17-2301 against multiresistant Pseudomonas aeruginosa strains. 1985

P Campos, and A Vera, and F Martin-Luengo

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776

Related Publications

P Campos, and A Vera, and F Martin-Luengo
In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
October 1985, The Journal of antimicrobial chemotherapy,
P Campos, and A Vera, and F Martin-Luengo
In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa.
June 1986, European journal of clinical microbiology,
P Campos, and A Vera, and F Martin-Luengo
In vitro activity of ciprofloxacin, azthreonam and ceftazidime against Serratia marcescens and Pseudomonas aeruginosa.
August 1984, European journal of clinical microbiology,
P Campos, and A Vera, and F Martin-Luengo
[In vitro activity of Ro 17-2301, a new monobactam antibiotic].
June 1985, Medicina clinica,
P Campos, and A Vera, and F Martin-Luengo
[In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
June 1986, Pathologie-biologie,
P Campos, and A Vera, and F Martin-Luengo
In-vitro evaluation of carumonam (Ro 17-2301).
September 1986, The Journal of antimicrobial chemotherapy,
P Campos, and A Vera, and F Martin-Luengo
In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosa.
May 1985, Antimicrobial agents and chemotherapy,
P Campos, and A Vera, and F Martin-Luengo
[New Virulent Bacteriophages Active against Multiresistant Pseudomonas aeruginosa Strains].
January 2015, Prikladnaia biokhimiia i mikrobiologiia,
P Campos, and A Vera, and F Martin-Luengo
In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
P Campos, and A Vera, and F Martin-Luengo
[In vitro study of the bacteriostatic and bactericidal activity of meropenem against strains of Pseudomonas aeruginosa multiresistant to antibiotics].
May 1996, Pathologie-biologie,
Copied contents to your clipboard!